Expression of Hepatocyte Growth Factor Activator and Hepatocyte Growth Factor Activator Inhibitor Type 1 in Human Hepatocellular Carcinoma
- 1 November 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 289 (1) , 205-211
- https://doi.org/10.1006/bbrc.2001.5916
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Hepatocyte Growth Factor/Scatter Factor Activates the Apoptosis Signaling Pathway by Increasing Caspase-3 Activity in Sarcoma 180 CellsBiochemical and Biophysical Research Communications, 1998
- Induction of Apoptosis by Hepatocyte Growth Factor/Scatter Factor and Its Augmentation by Phorbol Esters in Meth A CellsBiochemical and Biophysical Research Communications, 1998
- Expression of hepatocyte growth factor and its receptor c- met proto-oncogene in hepatocellular carcinomaHepatology, 1997
- Induction of Hepatocyte Growth Factor Activator Messenger Rna in the Liver Following Tissue Injury and Acute InflammationHepatology, 1997
- Hepatocyte Growth Factor Levels in Liver and Serum Increase During Chemical HepatocarcinogenesisHepatology, 1996
- Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: Its specific receptor c-met does.Hepatology, 1996
- Hepatocyte growth factor inhibits cell proliferation in vivo of rat hepatocellular carcinomas induced by diethylnitrosamineCarcinogenesis: Integrative Cancer Research, 1995
- Co‐expression of urokinase, urokinase receptor and PAI‐1 is necessary for optimum invasiveness of cultured lung cancer cellsInternational Journal of Cancer, 1995
- Serum hepatocyte growth factor levels in liver diseases: Clinical implicationsHepatology, 1995
- Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid β-protein precursorNature, 1989